Free US stock valuation multiples and PEG ratio analysis to identify reasonably priced growth companies with attractive risk-reward profiles. Our valuation framework helps you find stocks with the right balance of growth and value characteristics for your portfolio. We provide P/E analysis, PEG ratios, and relative valuation metrics for comprehensive valuation coverage. Find value in growth with our comprehensive valuation analysis and multiples tools for growth at a reasonable price strategies.
Arcellx Inc. (ACLX) is trading at $114.8 as of April 7, 2026, posting a modest 0.07% gain on the day. This analysis breaks down key technical levels, prevailing market context for the cell therapy developer, and potential scenarios to watch in upcoming trading sessions. No recent earnings data is available for the company as of the current date, so investor focus has been tilted toward technical price action and broader sector trends rather than quarterly fundamental results. The stock is curren
What is the short interest in Arcellx (ACLX) Stock | Price at $114.80, Up 0.07% - Private Capital
ACLX - Stock Analysis
4558 Comments
987 Likes
1
Valenica
Senior Contributor
2 hours ago
I wish I had been more patient.
👍 96
Reply
2
Haiely
Legendary User
5 hours ago
I had a feeling I missed something important… this was it.
👍 14
Reply
3
Kamilyah
Registered User
1 day ago
Great context provided for understanding market trends.
👍 217
Reply
4
Montoyia
Consistent User
1 day ago
Mind officially blown! 🤯
👍 37
Reply
5
Martwan
Insight Reader
2 days ago
I blinked and suddenly agreed.
👍 12
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.